| Revenues | | 5,368.00 | 5,527.00 | 5,289.00 | 5,271.00 |
| | 1,122.00 | - | - | - |
| Other Operating Expenses | | 1,122.00 | - | - | - |
| Operating Income/Loss | | 1,296.00 | 853.00 | 889.00 | 823.00 |
| Income/Loss From Equity Method Investments | | 51.00 | 83.00 | 64.00 | 61.00 |
| Income/Loss From Continuing Operations Before Tax | | 1,132.00 | 681.00 | 712.00 | 642.00 |
| Income Tax Expense/Benefit, Deferred | | -40.00 | -42.00 | 40.00 | 7.00 |
| Income Tax Expense/Benefit | | 226.00 | 37.00 | 133.00 | 120.00 |
| Income/Loss From Continuing Operations After Tax | | 702.00 | 371.00 | 342.00 | 288.00 |
| | 906.00 | 644.00 | 579.00 | 522.00 |
| Available To Common Stockholders, Basic | | 702.00 | 371.00 | 342.00 | 288.00 |
| Attributable To Noncontrolling Interest | | 204.00 | 273.00 | 237.00 | 234.00 |
| Basic Average Shares | | 86.80 | -0.96 | 87.95 | 91.14 |
| Diluted Average Shares | | 87.60 | -0.97 | 88.61 | 91.79 |
| Basic Earnings Per Share | | 8.09 | 4.24 | 3.89 | 3.16 |
| Diluted Earnings Per Share | | 8.01 | 4.21 | 3.86 | 3.14 |
THC
